| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO | President And CEO
2 companies
Riccitelli Samuel D is a President &CEO at Viridian Therapeutics, Inc.\DE with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $11.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2015 | VRDN Viridian Therapeutics, Inc.\de | President &CEO | Buy | 14,000 | $0.79 | $11,060.00 | +2.1% |